🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Soft Gel Capsule(s) Serving Size
80 Servings
Fat/Fatty Acid Product Type
17% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 {Calories}
Calories from Fat
15 {Calories}
Total Fat
1.5 g (2% DV)
Saturated Fat
Polyunsaturated Fat
0.5 g
Monounsaturated Fat
0.5 g
Oleic Acid
270 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 180mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 120mg UL 3000mg
Linoleic Acid
217 mg
Alpha-Linolenic Acid
71 mg
Gamma-Linolenic Acid
43 mg

Other Ingredients

Fish Body Oil Gelatin Glycerin Flax seed Oil Wheat Germ Oil Evening Primrose Oil Borage Oil Black Currant Oil natural Lemon flavor Caramel color Vitamin E Rosemary leaf extract

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

CONTAINS: Fish. Soybeans, Wheat.

🧪 Formulation Notes

No Sugar, No Starch, No Artifical Colors, No Preservatives, Sodium Free, No Corn, No Dairy, Yeast Free.

Additional Information

Store in a cool, dry place.

A unique conbination of omega-3, 6 and 9 fatty acids

CODE 753322 HGG

Conforms to USP <2091> for weight.

HEART

Made in the USA

Meets USP <2040> disintegration.

Product Details

UPC / SKU 0 48107 07338 1
DSLD Entry Date 2011-11-25
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 1838
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →